Table 2.
Cardiometabolic risk factors
| IFG | IGT | IFG + IGT | |
|---|---|---|---|
| SBP, mmHg | |||
| Pre | 130.6 ± 3.1 | 138.7 ± 6.7 | 135.0 ± 6.2 |
| Δ | −7.7 ± 5.9 | −17.8 ± 2.9* | −11.0 ± 4.1* |
| DBP, mmHg | |||
| Pre | 78.0 ± 3.8 | 83.3 ± 2.7 | 84.8 ± 4.2 |
| Δ | −5.7 ± 4.9 | −9.7 ± 2.2* | −9.8 ± 4.2* |
| FFA, mEq/l | |||
| Pre | 0.52 ± 0.03 | 0.57 ± 0.04 | 0.58 ± 0.5 |
| Δ | 0.03 ± 0.05 | −0.01 ± 0.04 | 0.01 ± 0.05 |
| TG, mg/dl# | |||
| Pre | 144.1 ± 23.5 | 136.9 ± 19.9 | 127.5 ± 19.6 |
| Δ | −52.8 ± 15.9* | −18.9 ± 18.4 | −25.3 ± 7.2* |
| TC, mg/dl | |||
| Pre | 209.5 ± 12.3 | 197.7 ± 7.5 | 198.8 ± 12.6 |
| Δ | −37.8 ± 9.7* | −15.4 ± 6.5* | −23.9 ± 5.3* |
| HDL, mg/dl | |||
| Pre | 42.8 ± 3.7 | 50.0 ± 5.9 | 42.4 ± 4.7 |
| Δ | −0.5 ± 2.1 | −5.7 ± 2.6 | −3.2 ± 2.4 |
| LDL, mg/dl | |||
| Pre | 130.1 ± 9.1 | 125.7 ± 8.5 | 136.1 ± 8.0 |
| Δ | −22 ± 9.3* | −6.1 ± 7.4 | −17.0 ± 4.0* |
Data are means ± SE. SBP, systolic blood pressure; DBP, diastolic blood pressure; FFA, free fatty acid; TG, triglyceride; TC, total cholesterol.
Data were log transformed for statistical analysis but are presented herein as raw values. ANOVA was performed to detect between-group differences. Within effect (paired t-test;
P < 0.05).